首页> 外文会议>MEDINFO >Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation
【24h】

Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation

机译:用于药物互动研究的正式证据类型定义,以改善证据基础策策

获取原文

摘要

In this research we aim to demonstrate that an ontology-based system can categorize potential drug-drug interaction (PDDI) evidence items into complex types based on a small set of simple questions. Such a method could increase the transparency and reliability of PDDI evidence evaluation, while also reducing the variations in content and seriousness ratings present in PDDI knowledge bases. We extended the DIDEO ontology with 44 formal evidence type definitions. We then manually annotated the evidence types of 30 evidence items. We tested an RDF/OWL representation of answers to a small number of simple questions about each of these 30 evidence items and showed that automatic inference can determine the detailed evidence types based on this small number of simpler questions. These results show proof-of-concept for a decision support infrastructure that frees the evidence evaluator from mastering relatively complex written evidence type definitions.
机译:在本研究中,我们的目标是证明基于本体的系统可以将潜在的药物 - 药物互动(PDDI)证据项目分类为基于一小部分简单问题。这种方法可以提高PDDI证据评估的透明度和可靠性,同时还降低了PDDI知识库中存在的内容和严重等级的变化。我们以44个正式的证据类型定义扩展了Dideo本体论。然后,我们手动注释了30个证据类型的证据类型。我们测试了一个关于这30个证据项目中的每一个的少数简单问题的RDF / owl表示,并显示了自动推理可以根据这种少量更简单的问题确定详细的证据类型。这些结果显示了决策支持基础设施的概念验证,这些基础设施将证据评估员掌握相对复杂的书面证据类型定义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号